Absci Corporation (ABSI) vs Korsana Biosciences, Inc. (KRSA)
- Absci Corporation ABSI 8.25 −7.09%
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
Absci Corporation and Korsana Biosciences, Inc. are both Biotechnology companies. Absci Corporation and Korsana Biosciences, Inc. are of similar size ($1.5B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against −62.3%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −7,756.4%) and the higher return on invested capital (−115.4% vs −174.7%). Across the 17 metrics below, Korsana Biosciences, Inc. leads on 10 and Absci Corporation on 7.
Valuation
Profitability
| Metric | ABSI | KRSA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (8,084.50%) | 0.00% | 0.00% |
| Net margin | (7,756.37%) | 0.00% | 0.00% |
| Free cash flow margin | (6,969.83%) | 0.00% | 0.00% |
| Return on equity | (57.72%) | (98.22%) | (56.36%) |
| Return on assets | (50.57%) | (82.29%) | (48.04%) |
| Return on invested capital | (174.74%) | (115.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack